In 2023, August J. Troendle earned $1.66M in total compensation at Medpace Holdings, Inc., including $825.00K salary and $814.42K bonus. Most recently sold 9,682 shares in May 2024. Currently holds stock worth $5.90B. Led Medpace Holdings, Inc. as CEO for 1 years.
Compensation History
Annual executive compensation data for August J. Troendle, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.66M
Salary
$825.00K
Bonus
$814.42K
Other
$17.33K
Salary
$825.00KBoard Justification
The company aims to align executive compensation with performance and market competitiveness, focusing on attracting and retaining top talent.
Bonus
$814.42KBoard Justification
Mr. Troendle earned 100% of his base salary as a cash bonus based on the company's financial performance and individual performance goals for 2023.
Other Compensation
$17.33KBoard Justification
Includes 401(k) matching contributions and incremental costs for personal usage of company-provided aircraft.
Restricted Stock
Board Justification
No stock awards vested in 2023 as the only stock grants mentioned are for future vesting.
Performance Metrics
Performance metrics for 2023 included EBITDA and revenue targets, with bonuses tied to achieving these goals.
August J. Troendle
Ex-CEO of Medpace Holdings, Inc.
Field of Expertise
Healthcare & Life Sciences - Healthcare
Sector of Economy
Healthcare
CEO of Medpace Holdings, Inc. for
1 year 0 months (Feb 2019 - Mar 2020)
Previous Experience
Unknown
Holdings
Track August J. Troendle's stock holdings and portfolio value over time.
Total Stock Sold
$1.10B
$1.10B
5,859,690 MEDP shares
What if they kept their stock?
If August J. Troendle didn't sell their stock, today they would have:
Extra MEDP5,859,690 shares worth $3.17B.
This is 187.95% and $2.07B more than what they got when they sold the stock.
Insider Trading
August J. Troendle's recent stock transactions, purchases, and sales filed with the SEC.
$3.83M
MEDP at $395.36/share
May 24, 2024
Sale
$22.00K
MEDP at $400.00/share
May 22, 2024
Sale
$1.61M
MEDP at $400.19/share
May 20, 2024
Sale
$15.90M
MEDP at $404.11/share
May 15, 2024
Sale
$2.00M
MEDP at $402.89/share
May 10, 2024
Sale
$3.31M
MEDP at $400.38/share
May 8, 2024
Sale
$21.12M
MEDP at $403.11/share
May 6, 2024
Sale
$6.55M
MEDP at $401.00/share
May 1, 2024
Sale
$6.78M
MEDP at $400.50/share
Apr 29, 2024
Sale
$82.16M
MEDP at $410.81/share
Mar 6, 2024
Sale
Rivals
Compare August J. Troendle with competitor CEOs and industry peers.
Andrew Dudum
Founder and CEO of Hims & Hers Health
2023 Compensation
Stock
$6.54M
Salary
$625.00K
Bonus
$1.14M
Other
$167.60K
Total Holdings
$42.54M
Gail K. Boudreaux
CEO of Elevance Health
2023 Compensation
Stock
$0.00
Salary
$1.60M
Bonus
$3.65M
Other
$840.96K
Total Holdings
$23.73K
Ari Bousbib
CEO of IQVIA
2023 Compensation
Stock
$28.10M
Salary
$1.80M
Bonus
$4.78M
Other
$0.00
Total Holdings
$15.00M